Tong targets online sales of ‘bootleg’ weight loss drugs

CTNewsJunkie – Thursday, May 22, 2025
By Karla Ciaglo

HARTFORD, CT — The online market for GLP-1 weight loss drugs is facing heightened scrutiny from Attorney General William Tong, who this week announced a dual enforcement action aimed at curbing the sale of unapproved and potentially dangerous compounds.

At a Hartford press conference, Tong announced a lawsuit against Florida-based Triggered Brand and an investigation into the global e-commerce site Made-in-China.com. Both are accused of marketing and selling unregulated GLP-1 mimetics — compounds that mimic drugs like semaglutide and tirzepatide — directly to consumers without prescriptions, medical supervision, or FDA approval.

Click here to read the entire article.